Variant report
Variant | nsv526861 |
---|---|
Chromosome Location | chr2:52036315-52038675 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370891918 | chr2:52037240-52037241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs34921698 | chr2:52037272-52037273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571345111 | chr2:52037285-52037286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs28966382 | chr2:52037326-52037327 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs141665370 | chr2:52037338-52037339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572030550 | chr2:52037370-52037371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540930781 | chr2:52037376-52037377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184640039 | chr2:52037396-52037397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574241585 | chr2:52037402-52037403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544825769 | chr2:52037411-52037412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534239398 | chr2:52037440-52037441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562919689 | chr2:52037472-52037473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533490392 | chr2:52037511-52037512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545065417 | chr2:52037512-52037513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187730147 | chr2:52037558-52037559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527634791 | chr2:52037573-52037574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150568778 | chr2:52037585-52037586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192703240 | chr2:52037596-52037597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531483001 | chr2:52037614-52037615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184098662 | chr2:52037657-52037658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571318269 | chr2:52037678-52037679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538745187 | chr2:52037693-52037694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189880796 | chr2:52037715-52037716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370785377 | chr2:52037740-52037741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375310959 | chr2:52037754-52037755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs17868258 | chr2:52037810-52037811 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs554250995 | chr2:52037849-52037850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574304805 | chr2:52037851-52037852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371854736 | chr2:52037863-52037864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538129495 | chr2:52037867-52037868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556733774 | chr2:52037882-52037883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181137908 | chr2:52037954-52037955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs574155062 | chr2:52037957-52037958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138558748 | chr2:52037967-52037968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141858524 | chr2:52037974-52037975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146269251 | chr2:52037986-52037987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1550101 | chr2:52038014-52038015 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs575333258 | chr2:52038050-52038051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184615532 | chr2:52038052-52038053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188980393 | chr2:52038078-52038079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549765335 | chr2:52038110-52038111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139562357 | chr2:52038117-52038118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532393673 | chr2:52038126-52038127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182035295 | chr2:52038127-52038128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565813786 | chr2:52038145-52038146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543233938 | chr2:52038213-52038214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372185464 | chr2:52038225-52038226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs186414067 | chr2:52038279-52038280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569517421 | chr2:52038289-52038290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538539987 | chr2:52038306-52038307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52037200-52037600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:52037600-52038400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr2:52038200-52039200 | Enhancers | Hela-S3 | cervix |
4 | chr2:52038400-52039600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |